S100A5 Attenuates Efficiency of Anti‐PD‐L1/PD‐1 Immunotherapy by Inhibiting CD8⁺ T Cell‐Mediated Anti‐Cancer Immunity in Bladder Carcinoma

Abstract

Although immune checkpoint blockade (ICB) therapies have been approved for bladder cancer (BLCA), only a minority of patients respond to these therapies, and there is an urgent need to explore combined therapies. Systematic multi‐omics analysis identified S100A5 as a novel immunosuppressive target for BLCA. The expression of S100A5 in malignant cells inhibited CD8+ T cell recruitment by decreasing pro‐inflammatory chemokine secretion. Furthermore, S100A5 attenuated effector T cell killing of cancer cells by inhibiting CD8+ T cell proliferation and cytotoxicity. In addition, S100A5 acted as an oncogene, thereby promoting tumor proliferation and invasion. Targeting S100A5 synergized with the efficacy of anti‐PD‐1 treatment by enhancing infiltration and cytotoxicity of CD8+ T cells in vivo. Clinically, there was a spatially exclusive relationship between S100A5+ tumor cells and CD8+ T cells in tissue microarrays. Moreover, S100A5 negatively correlated with immunotherapy efficacy in our real‐world and several public immunotherapy cohorts. In summary, S100A5 shapes a non‐inflamed tumor microenvironment in BLCA by inhibiting the secretion of pro‐inflammatory chemokines and the recruitment and cytotoxicity of CD8+ T cells. Targeting S100A5 converts cold tumors into hot tumors, thus enhancing the efficacy of ICB therapy in BLCA.

Clinical-mediated discovery of pyroptosis in CD8+ T cell and NK cell reveals melanoma heterogeneity by single-cell and bulk sequence

“…The cytometry panoramic tissue quantification assay developed by Li et al [41], known as TissueFAXS, was utilized to elucidate the distinct spatial roles of CD8 + T cells and NK cells. Figure 6A displays illustrative images demonstrating the presence of GZMA + and GSDMB + in tumor cells, accompanied by the infiltration of CD8 + T cells into the immune cell region.…”

Development and validation of glycosyltransferase related-gene for the diagnosis and prognosis of head and neck squamous cell carcinoma

“…ICI therapy has proven to be a useful treatment for carcinoma [ 43 – 45 ], and we observed that the risk score was negatively correlated with the immune checkpoints CTLA4, ICOS, and PDCD1, suggesting that the sensitivity to immunotherapy may differ among subgroups. The TIDE algorithm can effectively distinguish tumor immune escape and predict the efficacy of ICI therapy.…”

A systematic review and meta-analysis of magnetic resonance and computed tomography enterography in the diagnosis of small intestinal tumors

“…Given the limitations of traditional diagnostic methods, such as low morbidity, limited vigilance from doctors, and a lack of simple and non-invasive techniques, MR and CT enterography offer valuable clinical potential ( Hu et al, 2022 ). Both MR and CT enterography offer high-resolution imaging, enabling the visualization of small intestinal lesions from multiple perspectives and planes ( Li et al, 2023 ). MR enterography excels in providing clear images of the small intestinal lumen, external structures, and intestinal walls, whilst CT enterography allows the accurate display of morphological details and anatomical relationships between lesions in the small intestine and surrounding tissues ( Ma et al, 2022 ; Wang, Chen & Hu, 2022 ).…”